Drug Type Synthetic peptide |
Synonyms- |
Target |
Action- |
Mechanism TNFR1 modulators(Tumor necrosis factor receptor superfamily member 1A modulators), TNFR2 modulators(Tumor necrosis factor receptor superfamily member 1B modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Atherosclerosis | Discovery | - | 06 Oct 2022 | |
| Celiac Disease | Discovery | - | 06 Oct 2022 | |
| Immune System Diseases | Discovery | - | 06 Oct 2022 | |
| Inflammatory pain | Discovery | - | 06 Oct 2022 |





